Insight Trends

AI in Diagnostics Market Growth, Key Trends and Insights

AI in Diagnostics Market Growth and Key Insights

The global AI in diagnostics market was valued at $1.12 billion in 2023 and is projected to reach $12.65 billion by 2034, growing at a CAGR of 24.64%. This growth is driven by AI’s ability to reduce human error and improve diagnostic accuracy, aiding healthcare professionals in making better treatment decisions.

Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5244

Key Insights of the AI in Diagnostics Market

  • North America held the largest market share, accounting for 53% in 2023.
  • Asia Pacific is expected to see the fastest growth during the forecast period.
  • Software was the leading component in the market in 2023 and is anticipated to grow the quickest.
  • In terms of diagnosis, neurology dominated the market in 2023.
  • The radiology segment is expected to experience the fastest growth during the forecast period.

AI in Diagnostics Market Trends

  • Technological Advancements: AI in healthcare boosts efficiency and reduces errors, driving market growth.
  • Rising Chronic Disorders: Increasing cases of chronic diseases highlight the need for early and advanced diagnostic solutions.
  • Expanding Medical Device Sector: Growth in the medical device industry, fueled by investments and collaborations, supports market expansion.
  • Growing Research and Development: Ongoing research for early detection of chronic conditions is another key factor propelling market growth.

Radiology Segment: The Fastest Growing in AI Diagnostics

The radiology segment is expected to grow at the fastest rate in the AI in diagnostics market during the forecast period. AI has significant potential in radiology, already making a transformative impact on healthcare. AI algorithms are simplifying data interpretation and improving the diagnostic process, helping to address the growing demand for radiologists in the face of increasingly complex data. When combined with the expertise of radiologists and physicians, AI can enhance healthcare even further.

For example, in April 2024, Bayer and Google Cloud announced a partnership aimed at improving radiology and patient care. Bayer will use Google Cloud’s generative AI capabilities to expand its innovation platform, speeding up the development of AI-driven healthcare applications with a focus on radiology.

Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/ai-in-diagnostics-market-sizing

Access exclusive insight now @ https://www.towardshealthcare.com/price/5244

We’ve prepared a service to support you. Please feel free to contact us at  sales@towardshealthcare.com

Web: https://www.towardshealthcare.com

Visit Dental Specifics: https://www.towardsdental.com

Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare

Elena Morales

Elena Morales is a healthcare industry expert working at Healthcare Web Wire Consulting Firm, a subsidiary of Towards Healthcare. With her excellent knowledge of the field, Elena helps clients optimize their operations and navigate healthcare regulations. She's dedicated to staying updated on industry trends to make a positive impact on patient care. Elena is known for her professionalism and commitment to excellence, making her a valuable asset to any team.

Recent Posts

Kedrion Biopharma’s COAGADEX® Receives FDA Orphan Drug Designation for Acquired Factor X Deficiency (AFXD)

Kedrion Biopharma has announced that its human coagulation factor X concentrate, COAGADEX®, has been granted orphan drug designation by the… Read More

2 days ago

Benecard PBF and DecisionRX Join Forces to Personalize and Optimize Pharmacy Benefits

enecard PBF, a pioneer in pharmacy benefit facilitation, has announced a strategic partnership with DecisionRX, Inc., a leader in medication… Read More

2 days ago

Four Resilient Biotech Companies Making Waves in a Challenging Market

In a high-stakes biotech industry where drug development can span over a decade, four small but determined biotech companies are… Read More

2 days ago

Natera Launches TEODOR Trial in Partnership with ABCSG to Advance Personalized Breast Cancer Treatment

cell-free DNA and precision medicine, has officially announced the launch of the TEODOR trial (ABCSG 61), a groundbreaking phase 2,… Read More

2 days ago

Interventional Radiology Market: Size, Growth, and Leading Companies Driving Innovation

The global interventional radiology market is witnessing rapid expansion, driven by advancements in minimally invasive procedures, rising demand for diagnostic… Read More

2 days ago

Physical Therapy Market Growth and Leading Companies Driving Innovation

The global physical therapy market is valued at USD 28.06 billion in 2024, growing to USD 29.18 billion in 2025… Read More

2 days ago